MIV Therapeutics Announces Renowned Researcher to Detail Milestone,Pre-Clinical Results at Prominent International Conference EuroPCR,2007 ( com/>http://www.mivtherapeutics.com/ ...)

(Date:1/6/2009)...E, Md., Jan. 6 Sequella... focused on diseases of epidemic potential, announ...the treatment of tuberculosis (TB), was the first ...inical program contract to Dynport Vaccine Company...arded by the National Institute of Allergy and Inf...

(Date:1/5/2009)...ESDA, Md., Jan. 5 Microm...ompany developing novel, proprietary,antibodies f...mmune diseases,provides an outlook on key events...t intends to provide an update on its research and..., -- April 12 to 16, 2009: Update on several ...

(Date:12/27/2008)...D,S, Bermuda, Dec. 23 Wa...today that one of its subsidiaries and Mayne Pharm...of Hospira, Inc., have filed lawsuits against each..., Mylan Pharmaceuticals Inc. ("Mylan") and Impax L... for the District of New Jersey for infringement o...

(Date:12/17/2008)...est, Most Complex of Its Kind; 80 Percent of Traum..., Dec. 17 A multi-disciplinary tea...ntly performed the first near-total face transpla...procedure performed within the past two weeks, sur...o suffered severe facial trauma -- essentially rep...

Breaking Medicine Technology:Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2 Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3 Micromet Key Events for 2009 2 Micromet Key Events for 2009 3 Micromet Key Events for 2009 4 Micromet Key Events for 2009 5 Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 2 Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 3 Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant 2 Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant 3 Six Positive Predictions for 2008 from SuperLife World Service 8518 1 Six Positive Predictions for 2008 from SuperLife World Service 8518 2 ethiKids inc Launches Website and Products to Address Declining Ethics in Children 8516 1 ethiKids inc Launches Website and Products to Address Declining Ethics in Children 8516 2 China Sky One Medical Completes Previously Announced Amendments to Form 10QSB for the Second and Third Quarters of 2006 8514 1 China Sky One Medical Completes Previously Announced Amendments to Form 10QSB for the Second and Third Quarters of 2006 8514 2 AMDLs First Full Service JPGreen Health and Personal Care Center Set to Open in Hangzhou China 2287 1 AMDLs First Full Service JPGreen Health and Personal Care Center Set to Open in Hangzhou China 2287 2

[0] Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program [2] Micromet Key Events for 2009 [0] Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent [1] Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant

...ce suggests that if you,could choose your parents,...ase. Researchers from the long-standing,Framingham...t,Lung, and Blood Institute (NHLBI) of the Nation...parents live longer were more,likely to avoid deve...other risk factors for cardiovascular disease in m...

...3, 2007 -,Cytos Biotechnology AG (SWX:CYTN) report...ith CYT003-QbG10, an immunotherapeutic,product can... study,included 40 patients suffering from mild to...lergy (hay fever). The trial,investigated in a dou...oratory efficacy of two different formulations of ...

Other Medicine Technology:Framingham Study Shows Parents Who Live Long Pass On Lower Risk of,Cardiovascular Disease 2 Framingham Study Shows Parents Who Live Long Pass On Lower Risk of,Cardiovascular Disease 3 Placebo-controlled Phase IIa Study with the Immunotherapeutic,CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in,Hay Fever Patients 2 Placebo-controlled Phase IIa Study with the Immunotherapeutic,CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in,Hay Fever Patients 3 Placebo-controlled Phase IIa Study with the Immunotherapeutic,CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in,Hay Fever Patients 4 Placebo-controlled Phase IIa Study with the Immunotherapeutic,CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in,Hay Fever Patients 5 Placebo-controlled Phase IIa Study with the Immunotherapeutic,CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in,Hay Fever Patients 6 Placebo-controlled Phase IIa Study with the Immunotherapeutic,CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in,Hay Fever Patients 7

Framingham Study Shows Parents Who Live Long Pass On Lower Risk of,Cardiovascular Disease Placebo-controlled Phase IIa Study with the Immunotherapeutic,CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in,Hay Fever Patients

(Date:1/8/2009)...e introduces Senator Daschle at his confirmation h...n Services , , , WASHINGTON, Jan. 8 /PRNewswi...ounding board member Senator Tom Daschle, nominee ...ary, was introduced by fellow BPC founder and frie...day. The hearing was convened by the Senate Health...

(Date:1/8/2009)...pts Prenatal Solution Key Factor in Decision for F...RLANDO, Fla., Jan. 8 All...LLC, one of the largest multi-specialty group prac... the Allscripts Enterprise(TM) Electronic Health R...cians in 18 offices across Central Florida. , ...

(Date:1/8/2009)...lowered bad cholesterol more effectively than Zoco...-- After nearly a year of review, U.S. health offi...ued use of the controversial cholesterol-lowering ...ration said there was no significant difference in...Vytorin and patients taking the drug Zocor. , B...

(Date:1/8/2009)... local dance students will dance to raise money fo...IS, Jan. 8 , , , WHO: ...show off their talent in the 3rd annual Dance, ...ance Arts Centre. The, event will..., Participants raise money throu...

Breaking Medicine News(10 mins):Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 2 Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 3 Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 4 Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 2 Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 3 Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 4 Health News:FDA Backs Cholesterol Drug Vytorin 2 Health News:Dance With Courage to Benefit Camp Courage 2

[0] Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill [0] Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians [0] FDA Backs Cholesterol Drug Vytorin [0] Dance With Courage to Benefit Camp Courage

...a steroid nasal spray to quash allergy symptoms ma...s say that when used on an "as-needed'', rather th...se) relieves// allergy symptoms such as runny nose...vely than the antihistamine loratadine (Claritin)....

...on of intravenous magnesium sulfate to standard em...amide, appears to reduce rather than enhance the e...olleagues from the Albert Einstein College of Medi...vidence that magnesium may be helpful in the treat...

...who smoke during pregnancy are more likely to bear...higher risk than others because of genetic suscept...determine the causes of low birth weight, though t...mmending at this point that women be screened for ...

... of Swiss researchers found that butterbur extract...fects. Mr John de Carpentier said,presumably it co... would not work - and therefore it is possible tha...ons. It was used in treating hayfever The researc...

Other Medicine News:

Nasal Spray Beats Antihistamine Magnesium sulfate offers no help in migraine treatment Smoking Linked To Low Infant Birth Weight Butterbur does wonders

Aluminum Stylette 16 with Adjustable Stop.

Ultra-Slip™ endotracheal tube guide for single-patient use only., ,Caution: Not MRI Compatible.

Aluminum Stylette 16.

Ultra-Slip™ endotracheal tube guide for single-patient use only., ,Caution: Not MRI Compatible.

Medicine Products:

Aluminum Stylette with Adjustable Stop S5000N Ultra-Slip™ Stylet Aluminum Stylette S3000N Ultra-Slip™ Stylet

( com/>http://www.mivtherapeutics.com/ ...)MIV Therapeutics Announces Renowned Researcher to Detail Milestone,Pre-Clinical Results at Prominent International Conference EuroPCR,2007,Health